(RTTNews) - Genentech announced plans to invest more than $700 million in a new 700,000 square foot state-of-the-art drug manufacturing facility in Holly Springs, NC. The project will add more than 400 high-wage manufacturing jobs when the site is operational and more than 1,500 construction jobs during development. Roche and Genentech's current U.S. footprint includes 13 manufacturing and 15 R&D sites.
Genentech CEO Ashley Magargee said, "We are thrilled to establish this relationship with the city of Holly Springs, where we expect to have a positive impact on the local economy and community."
For More Such Health News, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
